Cleared Traditional

K791156 - AMIPAQUE MYELOGRAM TRAY

K791156 is an FDA 510(k) clearance for AMIPAQUE MYELOGRAM TRAY, manufactured by Pharmaseal Div., Baxter Healthcare Corp.. The device is a Class 2 General Hospital device with product code FMI cleared through the Traditional 510(k) pathway after a 39-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1979
Decision
39d
Days
Class 2
Risk

K791156 is an FDA 510(k) clearance for the AMIPAQUE MYELOGRAM TRAY. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Pharmaseal Div., Baxter Healthcare Corp. (Mchenry, US). The FDA issued a Cleared decision on July 30, 1979 after a review of 39 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K791156

510(k) Number K791156 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 21, 1979
Decision Date July 30, 1979
Days to Decision 39 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
90d faster than avg
Panel avg: 129d · This submission: 39d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 695
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K791156.
DOUBLE ENDED VENTED TRANSFER DEVICE
K801108 · Burron Medical Products, Inc. · May 1980
2 FR KELMAN CHAMBER MAINTAINER
K792096 · Heyer Schulte Corp. · Nov 1979
HYPERDERMIC NEEDLE WITH SENSOR #514
K791462 · Medtech Intl., Inc. · Sep 1979
BORDISPO BRAND HYPODERMIC NEEDLE
K790953 · Borda Products, Inc. · Jun 1979
NEEDLE, TRUCARE VACUTAINER
K790086 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Feb 1979
DILUTION SPIKE
K780209 · Sterling Drug, Inc. · Apr 1978